The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBUPF.L Regulatory News (BUPF)

  • There is currently no data for BUPF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-Stabilisation Notice - BUPA

30 Mar 2017 09:15

RNS Number : 0098B
Barclays Bank PLC
30 March 2017
 

 

pre-stabilisation announcement

30 March 2017

 

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

 

Bupa Finance plc 

Stabilisation Notice

 

Barclays debt syndicate desk; telephone: +44 20 7773 9098 hereby gives notice that the Stabilising Manager(s) named below may stabilise the offer of the following securities in accordance with Commission Regulation (EC) No. 2273/2003 implementing the Market Abuse Directive (2003/6/EC).

 

The securities:

Issuer:

Bupa Finance plc

Guarantor (if any):

The British United Provident Association Limited

Aggregate nominal amount:

TBA

Description:

Senior Unsecured, Unsubordinated, Reg S, Bearer GBP Benchmark

Offer price:

 TBA

Stabilisation:

Stabilisation Manager(s):

Barclays

HSBC

NatWest Markets

Santander

Standard Chartered Bank

Stabilisation period expected to start on:

30 March 2017

Stabilisation period expected to end no later than:

30 April 2017

Existence, maximum size and conditions of use of over-allotment facility.

The Stabilising Manager(s) may over-allot the securities to the extent permitted in accordance with applicable law.

 

In connection with the offer of the above securities, the Stabilising Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilising Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the "Prospectus Directive") before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Prospectus Directive (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Directive), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Directive (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STAWGUWGWUPMURU
Date   Source Headline
2nd Mar 20237:00 amRNSBupa Finance 2022 Annual Report
4th Aug 20227:00 amRNSBupa Finance Announces Half Year Results
8th Mar 20227:00 amRNSBupa Finance plc 2021 Annual Report
27th Oct 20213:12 pmRNSPost Stabilisation Notice
24th Sep 20212:01 pmRNSFinal Issue and Tender Offer Results
23rd Sep 202110:28 amRNSIssue of Debt
22nd Sep 20211:49 pmRNSFinal Result Tender Offer Fixed Rate Sub Notes2023
22nd Sep 202110:55 amRNSIndicative Tender Offer Result
14th Sep 20219:34 amRNSTender Offer
5th Aug 20217:00 amRNSBupa Finance plc Half Year Report 2021
26th May 20214:09 pmRNSChange of Auditor
4th Mar 20217:00 amRNSAnnual Financial Report
7th Aug 20207:00 amRNSBupa Finance plc Half Year Report 2020
5th Aug 20202:34 pmRNSBupa to redeem £330m subordinated 2004 bonds
23rd Jun 20203:59 pmRNSBupa publishes Prospectuses for Note Offerings
18th Jun 20204:51 pmRNSBupa announces price of Fixed & Subordinated Notes
27th Apr 20201:39 pmRNSProspectuses: Uploaded to NSM
9th Apr 20201:13 pmRNSMoody’s affirms Bupa Insurance Limited’s Rating
31st Mar 202011:46 amRNSFitch downgrades Bupa Finance plc’s credit rating
5th Mar 20207:00 amRNSAnnual Financial Report
1st Aug 20197:00 amRNSBupa Finance Half Year Report 2019
14th Mar 20197:00 amRNSAnnual Financial Report
2nd Aug 20184:58 pmRNSHalf-year Report - Replacement
2nd Aug 20187:00 amRNSHalf-year Report
8th Mar 20187:04 amRNSAvailability of Annual Report
3rd Aug 20177:05 amRNSHalf-year Report
12th Apr 20179:22 amRNSPost-Stabilisation Notice - Bupa Finance
3rd Apr 20172:02 pmRNSBupa Finance plc publishes Prospectus
31st Mar 20177:00 amRNSBupa Finance plc £300m 2% Fixed Rate Note due 2024
30th Mar 20179:15 amRNSPre-Stabilisation Notice - BUPA
2nd Mar 20177:05 amRNSBupa Finance plc - Annual Financial Report 2016
10th Feb 20177:00 amRNSBupa completes acquisition of Oasis Dental Care
12th Dec 20161:24 pmRNSPost Stabilisation Notice - Bupa Finance plc
6th Dec 20163:05 pmRNSPublication of a Prospectus
2nd Dec 20167:00 amRNSPricing
1st Dec 201610:15 amRNSStabilisation Notice
18th Nov 20167:00 amRNSBupa to acquire Oasis Dental Care
4th Aug 20167:05 amRNSHalf-year Report
18th Mar 20161:32 pmRNSBupa Finance plc - Annual Financial Report 2015
13th Aug 20154:29 pmRNSBupa Finance plc - 2015 Half Year Report
24th Apr 201511:04 amRNSAnnual Financial Report
13th Jun 20144:40 pmRNSBupa Finance plc prospectus £350m 3.375% Notes
12th Jun 20147:00 amRNSChange of Auditor
29th Apr 20143:04 pmRNSAnnual Financial Report
30th Oct 20136:00 pmRNSRedemption of £100m 10.5per cent. Subord Bond 2018
6th Jun 20133:00 pmRNSPost Stabilisation - Bupa
23rd Apr 201312:49 pmRNSBupa Finance plc prospectus re £500m 5% Notes 2023
18th Apr 20139:14 amRNSStabilisation Notice - Bupa
26th Mar 201310:40 amRNSAnnual Financial Report
23rd Apr 20122:09 pmRNS2011 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.